FDA and MHRA Guidance during the COVID-19 Emergency: Conduct of Clinical Trials
Instructor:
Mark Powell
Product ID: 706477
Training Level: Intermediate
- Duration: 60 Min
Why Should You Attend:
The COVID-19 pandemic has disrupted clinical trials in a number of ways, including site closures, travel restrictions, supply chain interruptions and unavoidable protocol deviations or modifications.
The webinar will enable participants to adopt a risk-based, compliant response to the challenges posed by COVID-19 to the conduct of clinical trials.
Areas Covered in the Webinar:
- Safeguarding patient safety
- Alternative approaches for products normally administered at the clinic
- Informed consent by quarantined patients
- Availability of clinical trial supplies
- Subject enrollment
- Handling protocol deviations
- Approval of protocol amendments
- Monitoring of trial participants
- Access to medical records
- Pausing clinical trials
Who Will Benefit:
- Clinical investigators
- Clinical trial sponsors
- Manufacturers of clinical trial supplies
- Regulatory affairs professionals
- Clinics undertaking human trials
- Pharmaceutical manufacturers
Free Materials:
- Reference documents
- Rule documents or guidance
- Checklist
- SOP template
- Easy fill in forms
- Articles
Mark Powell
Director, Mark Powell Scientific Limited
Dr Mark Powell a Fellow of the Royal Society of Chemistry (RSC) with over thirty years’ experience as a senior analytical chemist. Mark was Honorary Treasurer of the RSC’s Analytical Division and led a working group on continuing professional development until July 2016. He has worked at a senior level in a number of companies with responsibility for method development and equipment qualification. In 2010 Mark was appointed Scientific Manager of a UK-based pharmaceutical CRO, with responsibility for guiding the direction of drug development programs as well as establishing collaborations with academia and instrument manufacturers. His work resulted in a number of published papers and presentations at international scientific conferences. In 2013, he set up his own company to provide training and consultancy services to pharmaceutical professionals. His consultancy work has involved, amongst other things, managing the analytical aspects of pharmaceutical development programs and conducting data integrity audits. He is in demand as a trainer in topics such as chromatography, spectroscopy, pharmaceutical dissolution testing, data integrity, control of impurities, technical writing, stability/stress studies and sample preparation.
Refund Policy
Our refund policy is governed by individual products and services refund policy mentioned against each of offerings. However in absence of specific refund policy of an offering below refund policy will be effective.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange. Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time. On-Demand Recording purchases will not be refunded as it is available for immediate streaming. However if you are not able to view the webinar or you have any concern about the content of the webinar please contact us at below email or by call mentioning your feedback for resolution of the matter. We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email [email protected] call +1-888-717-2436 (Toll Free).
